UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Mutual Advisors LLC

Mutual Advisors LLC cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 9.4% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 16,732 shares of the healthcare conglomerate’s stock after selling 1,733 shares during the period. Mutual Advisors LLC’s holdings in UnitedHealth Group were worth $8,763,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Geode Capital Management LLC raised its position in UnitedHealth Group by 1.6% during the fourth quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate’s stock valued at $10,068,869,000 after buying an additional 319,515 shares during the period. Capital International Investors lifted its position in shares of UnitedHealth Group by 6.2% in the fourth quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate’s stock worth $7,899,905,000 after purchasing an additional 906,365 shares in the last quarter. Norges Bank purchased a new position in UnitedHealth Group during the fourth quarter valued at approximately $6,375,744,000. Northern Trust Corp lifted its position in UnitedHealth Group by 12.5% in the 4th quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate’s stock worth $4,807,527,000 after buying an additional 1,058,488 shares in the last quarter. Finally, Franklin Resources Inc. boosted its position in UnitedHealth Group by 10.7% during the fourth quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate’s stock valued at $4,514,178,000 after purchasing an additional 861,854 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 589 shares of the business’s stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the transaction, the chief executive officer directly owned 10,398 shares in the company, valued at approximately $3,171,390. The trade was a 5.36% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Kristen Gil purchased 3,700 shares of UnitedHealth Group stock in a transaction dated Thursday, May 15th. The stock was bought at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the acquisition, the director directly owned 3,818 shares of the company’s stock, valued at approximately $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired a total of 109,408 shares of company stock worth $31,607,768 in the last three months. 0.28% of the stock is owned by insiders.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $307.69 on Thursday. The firm has a market cap of $279.12 billion, a price-to-earnings ratio of 12.88, a PEG ratio of 1.55 and a beta of 0.45. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The stock has a 50-day moving average price of $329.50 and a 200 day moving average price of $450.21.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter in the previous year, the firm posted $6.91 EPS. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were issued a $2.21 dividend. The ex-dividend date of this dividend was Monday, June 16th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a yield of 2.87%. UnitedHealth Group’s dividend payout ratio (DPR) is 37.02%.

Analysts Set New Price Targets

Several equities analysts recently weighed in on UNH shares. KeyCorp cut their price objective on shares of UnitedHealth Group from $450.00 to $400.00 and set an “overweight” rating on the stock in a research report on Monday, June 2nd. JPMorgan Chase & Co. raised their target price on UnitedHealth Group from $405.00 to $418.00 and gave the company an “overweight” rating in a report on Friday, June 20th. Truist Financial restated a “buy” rating and issued a $360.00 target price (down from $580.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Hsbc Global Res downgraded shares of UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a report on Wednesday, May 21st. Finally, TD Cowen lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 target price for the company. in a research report on Monday, May 19th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $415.57.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.